MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The monoclonal antibody cytomegalovirus retinitis trial'. Together they form a unique fingerprint.

Medicine & Life Sciences